Sort
50,496 grants matching “lung cancer”
Leveraging deep learning for markerless motion management in radiation therapy
$411,262Lei Xing · Stanford University · R01 · FY2024 · CA
Impact of nucleotide metabolism on bacterial clearance
$411,250Sebastian Alejandro Riquelme Colet · Columbia University Health Sciences · R35 · FY2024 · GM
Impact of nucleotide metabolism on bacterial clearance
$411,250Sebastian Alejandro Riquelme Colet · Columbia University Health Sciences · R35 · FY2025 · GM
Impact of nucleotide metabolism on bacterial clearance
$411,250Sebastian Alejandro Riquelme Colet · Columbia University Health Sciences · R35 · FY2023 · GM
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
$411,223Humam Kadara · University Of Tx Md Anderson Can Ctr · U01 · FY2024 · CA
Novel applications and translation of [18F]hGTS13, a system xc- specific radiopharmaceutical
$411,206Jianghong Rao · Stanford University · R01 · FY2024 · CA
MATCHMAKERS: Solving T-cell receptor recognition and design via integrated high-throughput screening and structural, functional and computational approaches
$411,201Stephen J Elledge · Brigham And Women'S Hospital · OT2 · FY2025 · CA
Noncovalent interaction of mutant KRAS inhibitors
$411,152Jen-Tsan Ashley Chi · Duke University · R21 · FY2025 · CA
Inhibition of Radiation-Induced Coronary Microvascular Disease
$411,136Saraswati Pokharel · Roswell Park Cancer Institute Corp · R01 · FY2025 · HL
Basic Mechanisms in Lung Disease
$411,131University Of Alabama At Birmingham · T32 · FY2003 · HL
Functional Determinants of Metastatic Dormancy
$411,127Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
MEK AND PI3K INHIBITION IN THE REGULATION OF PANCREATIC CANCER METABOLISM
$411,122Lewis C Cantley · University Of Tx Md Anderson Can Ctr · P01 · FY2014 · CA
Organic cation transporter 2 and cisplatin nephrotoxicity
$411,104Alexander Sparreboom · St. Jude Children'S Research Hospital · R01 · FY2010 · CA
Phase I/II Trial of ZD1839 and Celecoxib in Ex-Smokers
$411,067Duke University · U01 · FY2002 · CA
Impact of Direct to Consumer Genetic Testing
$411,045Robert C. Green · Boston University Medical Campus · R01 · FY2010 · HG
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort
$410,983Wei-Qi Wei · Vanderbilt University Medical Center · R01 · FY2019 · HL
Lung Epithelial-Mesenchymal Interactions in Adenocarcinoma Invasion
$410,977Charles A. Powell · Columbia University Health Sciences · R01 · FY2008 · CA
Project 3: Arsenic Biomarker Epidemiology
$410,861Allan H Smith · University Of California Berkeley · P42 · FY2009 · ES
Development of a first-in-class mEGFR dimerization inhibitor
$410,837Mukesh K. Nyati · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Development of a first-in-class mEGFR dimerization inhibitor
$410,837Mukesh K. Nyati · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Studies on the effects of a novel intermittent therapy on intratumoral clonal architecture and resistance
$410,835Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Dissecting KRAS oncoprotein signaling with allele specific inhibitors
$410,835Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Studies on the effects of a novel intermittent therapy on intratumoral clonal architecture and resistance
$410,835Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
C16-Ceramide Nano-Liposomes Reverse Multi-Drug Resistance
$410,835Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Dissecting KRAS oncoprotein signaling with allele specific inhibitors
$410,835Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA